Shareholding disclosure

Astellas Pharma Inc

Declared position

9.931%

Threshold

Crossed upwards

Timeline

Published

25.01.2014

Transaction

22.01.2014

Voting rights breakdown

Voting rights acquired9.931%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE1O00031

Beneficial owner

Astellas Pharma Inc

Declared address

Astellas Pharma Inc., 103-8411 Tokyo

Astellas Venture Capital LLC, P.O. Box 7585, Menlo Park, CA 94026, United States, which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Astellas Pharma Inc

HBM Healthcare Investments AG25.01.2014TAE1O00031

Disclosure summary

Astellas Pharma Inc disclosed a holding in HBM Healthcare Investments AG on the acquisition side, published by SIX Exchange Regulation on 25.01.2014, at 9.931% of voting rights. Notice category: Single shareholder.

Disclosed position

9.931%

Voting rights acquired

Voting rights acquired9.931%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Astellas Pharma Inc disclosed a holding in HBM Healthcare Investments AG, published on 25.01.2014.

Publication date25.01.2014

Transaction date22.01.2014

Issuing companyHBM Healthcare Investments AG

Beneficial ownerAstellas Pharma Inc

Declared addressAstellas Pharma Inc., 103-8411 Tokyo

CategorySingle shareholder

Voting rights acquired9.931%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE1O00031

Conditions

Astellas Venture Capital LLC, P.O. Box 7585, Menlo Park, CA 94026, United States, which is a 99.9% subsidiary of Astellas US Holding, Inc.,1 Astellas Way Northbrook, IL 60062, which is wholly owned subsidiary of Astellas Pharma Inc., Japan. (beneficial owner)

Source: SIX Exchange Regulation · Publication date: 25.01.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open